Introduction Bronchiectasis is a multidimensional disease associated with substantial
morbidity and mortality. Two disease-specific clinical prediction tools have been developed …

The clinical course of bronchiectasis is unpredictable, posing a challenge both in clinical
practice and in research. Two mortality prediction scores, the bronchiectasis severity index …

Background Patients with bronchiectasis often have concurrent comorbidities, but the
nature, prevalence, and impact of these comorbidities on disease severity and outcome are …

Rationale: There are no risk stratification tools for morbidity and mortality in bronchiectasis.
Identifying patients at risk of exacerbations, hospital admissions, and mortality is vital for …

Background Although the FACED score has demonstrated a great prognostic capacity in
bronchiectasis, it does not include the number or severity of exacerbations as a separate …

Background The FACED score is an easy-to-use multidimensional grading system that has
demonstrated an excellent prognostic value for mortality in patients with bronchiectasis. A …

Bronchiectasis is a multidimensional disease and, therefore, its severity or prognosis cannot
be adequately quantified by analysing one single variable. The objective of the present …

Background Identifying risk factors for poor outcomes can help with risk stratification and
targeting of treatment. Risk factors for mortality and exacerbations have been identified in …

Bronchiectasis is one of the most neglected diseases in respiratory medicine. There are no
approved therapies and few large-scale, representative epidemiological studies. The …

Bronchiectasis (BE) is a chronic and progressive respiratory disease with multiple possible
causes [1, 2]. Many require a specific therapy and thus, a systematic aetiologic evaluation is …